| Accession |
PRJCA016516 |
| Title |
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX10 in Combination with HLX04 in Patients with Advanced Solid Tumors |
| Relevance |
Medical |
| Data types |
PK and ADA
|
| Organisms |
Homo sapiens
|
| Description |
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (HLX10) in Combination with Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection (HLX04) in Patients with Advanced Solid Tumors |
| Sample scope |
Multiisolate |
| Release date |
2023-04-25 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Li
Jin (lijin@csco.org.cn)
|
| Organization |
Shanghai East Hospital |
| Submission date |
2023-04-24 |
